Results 1 to 10 of about 1,735 (146)
中西医结合护理, 2021 This paper summarized the nursing of integrated Traditional Chinese and western medicine for a patient undergoing thrombolytic therapy for acute mesenteric venous thrombosis.
TONG Fenfei (仝粉飞) +3 more
doaj +3 more sources
Wireless Communications and Mobile Computing, Volume 2021, Issue 1, 2021., 2021 Clinical named entity recognition (CNER) identifies entities from unstructured medical records and classifies them into predefined categories. It is of great significance for follow‐up clinical studies. Most of the existing CNER methods fail to give enough thought to Chinese radical‐level characteristics and the specialty of the Chinese field.
Yue Wu +6 more
wiley +1 more source
Zhongguo cuzhong zazhi, 2022 目的 探索在中国县级医院条件下，急性缺血性卒中患者经急诊MRI筛选后进行超时间窗溶栓的安全性和有效性以及在中国基层卒中中心进行影像学指导超时间窗溶栓的可行性。 方法 前瞻性连续纳入2021年7月-2022年1月江西省兴国县人民医院经头颅MRI筛选后符合影像错配（DWI序列高信号-FLAIR序列等信号）标准并进行超时间窗静脉溶栓的首次急性缺血性卒中患者为超时间窗溶栓组。以同时间段标准溶栓时间窗内（发病4.5 h内）静脉溶栓的急性缺血性卒中患者为对照组（标准时间窗溶栓组 ...
鲁燕1 ，杨保荣1 ，黄向萍1 ，杨冠桂2 ，陈圣文3 ，李建荣4 ，曾小明1
doaj +1 more source
Zhongguo cuzhong zazhi, 2023 目的 评估我国2016—2022年发病6 h内急性缺血性卒中患者静脉溶栓的变化趋势，并比较rt-PA与尿激酶静脉溶栓的院内临床结局差异。 方法 纳入中国卒中中心联盟（Chinese Stroke Center Alliance，CSCA）2016年1月—2022年12月登记的发病6 h内到院的急性缺血性卒中患者555 991例，计算各年份rt-PA静脉溶栓和尿激酶静脉溶栓的比例变化。采用多因素logistic回归法，以rt-PA溶栓为对照，分析尿激酶溶栓对院内脑梗死出血转化 ...
宗黎霞1，谷鸿秋2，杨昕2，姜英玉2，李子孝1，2，王春娟1，2
doaj +1 more source
Analysis of early efficacy and safety of endovascular therapy for acute mild ischemic stroke with large vessel occlusion [PDF]
, 2023 Objective·To investigate the early efficiency and safety of endovascular therapy (EVT) for patients with acute mild ischemic stroke with large vessel occlusion (LVO-MIS).Methods·A total of 31 patients with LVO-MIS who received emergency EVT-assisted ...
CAO Li +3 more
core +1 more source
中西医结合护理, 2023 Objective To investigate the effect of quality control circle (QCC)activities in improving the standardized implementation rate of peripheral venous thrombolysis for lower-limb deep venous thrombosis (DVT). Methods A QCC group was set up.
BAI Mei (白枚) +5 more
doaj +1 more source
Zhongguo cuzhong zazhi, 2023 目的 对比双联抗血小板与阿替普酶静脉溶栓治疗急性轻型非致残性缺血性卒中的近期临床疗效和安全性。 方法 前瞻性连续入组发病时间4.5 h内的轻型非致残性缺血性卒中（NIHSS评分≤5分，各分项单项得分≤1分且意识项为0分）患者，随机分为溶栓组和双抗组。给予溶栓组患者阿替普酶（0.9 mg/kg）静脉溶栓治疗，给予双抗组患者阿司匹林肠溶片联合硫酸氢氯吡格雷片双抗治疗。评估患者治疗后7 d、14 d的NIHSS评分，并记录早期神经功能恶化、14 d内出现的出血事件。 结果 共入组131例符合纳入标准的患者，
李振华1，张建刚1，谢卫征1，王禹2，罗雪1，刘聪慧1，孙科1，杨清成1，郭艳平1
doaj +1 more source
Percutaneous mechanical thrombectomy in the treatment of acute iliofemoral deep vein thrombosis: a systematic review [PDF]
, 2019 BACKGROUND: Conventional treatment of deep vein thrombosis (DVT) of the lower extremities by anticoagulation alone has been proven to be insufficient to prevent recurrence and post-thrombotic syndrome (PTS).
Chan, YC, Cheng, SWK, Law, Y, Wong, PC
core +1 more source
溶栓后出血评分的临床应用及进展 Progress and Application of Hemorrhage Risk Score after Thrombolysis
Zhongguo cuzhong zazhi, 2019 【摘要】 静脉溶栓是治疗缺血性卒中有效的方法。出血转化是静脉溶栓后严重的并发症之一。溶栓后出血评分是评估缺血性卒中患者溶栓后出血转化发生率的预测模型，它的3项评价指标分别为卒中患者的血糖水平、卒中后临床严重程度及影像学数据。本文介绍了溶栓后出血评分的3项预测因素与溶栓后出血转化的关系，并对该评分的临床应用及进展进行了综述。 【Abstract】 Intravenous thrombolysis is an effective treatment way of acute ischemic ...
刘琪，张玉梅
doaj +1 more source
Effect of Acupuncture as an Adjuvant Therapy for Intravenous Thrombolytic Treatment on Peripheral Inflammatory Factors and Neurologic Function in Patients with Acute Ischemic Stroke [PDF]
, 2022 BackgroundAcupuncture has proved effective in reducing inflammatory cytokine levels. However, it is still unclear about its improvement on the neurologic function and activities of daily living as well as over all clinical efficacy in patients with acute
CHEN An, CAO Xiao, ZHANG Huilin, LIAN Jianfeng
core +1 more source